Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hrubisko

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
Vnitrni Lekarstvi|January 1, 1974
[Hemolytic anemia as an early manifestation of chronic inflammatory processes of the kidney]A Sakalová, M Steruská, M Hrubisko
Vnitrni Lekarstvi|June 1, 1970
[New variants of the blood groups ABO (H) caused by interaction of recessive genes, directing the formation of H antigen in erythrocytes: phenotype Bombay-like variants O Hm, O B Hm, O AB Hm]M Hrubisko, J Laluha, O Mergancová, et al.
Biochemical Pharmacology|January 7, 1993
The role of metallothionein, glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agentsM Hrubisko, A T McGown, B W Fox
Vnitrni Lekarstvi|October 1, 1980
[Sézary's syndrome with an unusual immunologic picture]A Sakalová, M Hrubisko, J Jakubovský, et al.
Vnitrni Lekarstvi|February 1, 1979
[Pulmonary immune reaction following transfusion of mixed plasma]A Filová, V Drobná, K Hrubisková, et al.
Vnitrni Lekarstvi|August 1, 1986
[Selection of blood donors for cytopheresis and its effect on their health status]K Sviteková, E Fehérvízyová, A Pajdlhauserová, et al.
Bratislavske Lekarske Listy|February 1, 1987
[Incidence of the Pelger-Hüet anomaly]I Chabronová, M Hrubisko, M Steruská, et al.
Vnitrni Lekarstvi|December 1, 1989
[Blood group Du]M Hrubisko, D Cupaníková, L Ceizelová, et al.
Neoplasma|January 1, 1973
Clinical utilization of plasmapheresis and cyclophosphamide in the treatment of malignant lymphoproliferative processesA Sakalová, S Gazová, M Hrubisko, et al.
Casopis Lekaru Ceskych|October 10, 1980
[Two observations of an anti-Pr antibody (author's transl)]L Ceizelová, M Hrubisko, E Bastrnáková, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Vnitrni Lekarstvi|January 1, 1974
[Hemolytic anemia as an early manifestation of chronic inflammatory processes of the kidney]A Sakalová, M Steruská, M Hrubisko
Vnitrni Lekarstvi|June 1, 1970
[New variants of the blood groups ABO (H) caused by interaction of recessive genes, directing the formation of H antigen in erythrocytes: phenotype Bombay-like variants O Hm, O B Hm, O AB Hm]M Hrubisko, J Laluha, O Mergancová, et al.
Biochemical Pharmacology|January 7, 1993
The role of metallothionein, glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agentsM Hrubisko, A T McGown, B W Fox
Vnitrni Lekarstvi|October 1, 1980
[Sézary's syndrome with an unusual immunologic picture]A Sakalová, M Hrubisko, J Jakubovský, et al.
Vnitrni Lekarstvi|February 1, 1979
[Pulmonary immune reaction following transfusion of mixed plasma]A Filová, V Drobná, K Hrubisková, et al.
Vnitrni Lekarstvi|August 1, 1986
[Selection of blood donors for cytopheresis and its effect on their health status]K Sviteková, E Fehérvízyová, A Pajdlhauserová, et al.
Bratislavske Lekarske Listy|February 1, 1987
[Incidence of the Pelger-Hüet anomaly]I Chabronová, M Hrubisko, M Steruská, et al.
Vnitrni Lekarstvi|December 1, 1989
[Blood group Du]M Hrubisko, D Cupaníková, L Ceizelová, et al.
Neoplasma|January 1, 1973
Clinical utilization of plasmapheresis and cyclophosphamide in the treatment of malignant lymphoproliferative processesA Sakalová, S Gazová, M Hrubisko, et al.
Casopis Lekaru Ceskych|October 10, 1980
[Two observations of an anti-Pr antibody (author's transl)]L Ceizelová, M Hrubisko, E Bastrnáková, et al.
Pageof 12